skip to main content

News and Events

Recent Releases

01/10/2023 - 8:45am

With new award, Rogel researchers will work to bring equity to AYA cancer research and outcomes

Anao Zhang, Ph.D., LCSW, ACSW, ACBT is principal investigator on a new project funded with a $250,000 Eugene Washington PCORI Engagement Award, an initiative of the Patient-Centered Outcomes Research Institute, or PCORI. The research team will build out existing research infrastructure in patient-centered outcomes to enhance participation from AYA cancer survivors who identify as BIPOC or sexual and gender minorities.

12/07/2022 - 9:15am

ASH 2022 Annual Meeting will be held Dec. 10-13

Rogel Cancer Center faculty and trainees will lead more than two dozen presentations, posters and moderated sessions at the American Society of Hematology annual meeting. This year’s meeting will be held in-person and virtually.

12/06/2022 - 10:45am

Rogel researchers receive $4M through Prostate Cancer Foundation’s inaugural TACTICAL awards program

Principal investigator Arul Chinnaiyan, M.D., Ph.D., will lead a $4 million project that will employ a suite of cutting-edge drug development techniques to develop an effective inhibitor of MYC, a major driver of about 70% of all cancers, including prostate cancer.

11/18/2022 - 10:30am

Rogel researcher gets $792K Discovery Science grant from American Cancer Society

As part of its Discovery Science grants program, the American Cancer Society has awarded Rogel Cancer Center researcher Anthony Scott, M.D., $792,000 to look at how genes associated with Lynch syndrome impact cancer developing.

11/08/2022 - 9:30am

Patients with metastatic breast cancer and a chronic health condition have poorer outcomes

The death rate for women with metastatic breast cancer is linked to the number of chronic health conditions they have, according to a study by the University of Michigan in partnership with the Kaiser Permanente Southern California Department of Research & Evaluation.

All Releases